Pak2 activation thus protects against ventricular arrhythmia associated with cardiac stress and hypertrophy, through unique mechanisms offering potential novel therapeutic anti‐arrhythmic targets. The gene discussed is PAK2; the disease is Ventricular arrhythmia.